Parathyroid Hyperplasia in Patients With Chronic Kidney Disease.

• Conditions: Chronic Kidney Diseases

• Registration Number: NCT03182517
• Lead Sponsor: Assiut University

Brief Summary

Secondary hyperparathyroidism is an important complication in patient with chronic kidney disease . It is associated with bone complication and an increase in cardiovascular mortality The parathyroid hormone rises in these patients as consequence of low concentration of vitamin D3 ,reduction in quantities of serum calcium, phosphorus retention and reduction of vitamin D receptors sensitive to calcium.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2017-06-08
• Study First Submitted QC: 2017-06-08
• Study First Posted: 2017-06-09
• Study Start: 2018-02-01
• Status Verified: 2018-06
• Last Update Submitted: 2018-06-26
• Last Update Posted: 2018-06-27
• Primary Completion: 2018-08
• Study Completion: 2018-11

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• stage 5 chronic renal failure
• dialysis (peritoneal ,or hemodialysis) since 3---5 years

Read More

Exclusion Criteria

• previous of neck surgery.
• Patients refusal to participate in the study or voluntary withdrawal

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The percentage of patients with high parathyroid hormone level	1 day	laboratory measurement of parathyroid hormone

Trial Locations

Locations (1)

Assiut Faculty of Medicine; 🇪🇬 Assiut, Egypt